X
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
0
https://www.accesswire.com/739969/Jaguar-Health-Achieves-Approximately-75-Enrollment-in-Pivotal-Phase-3-OnTarget-Trial-of-Crofelemer-for-Cancer-Therapy-Related-Diarrhea
https://www.accesswire.com/713157/Jaguar-Health-Announces-that-Orphan-Drug-Designation-Application-Submitted-to-the-FDA-for-Crofelemer-for-a-Severe-Congenital-Diarrheal-Disorder-CDD-Has-Been-Accepted-for-Review
https://www.accesswire.com/686514/Jaguar-Health-Announces-Completion-of-Third-party-Investigator-Initiated-Study-of-Crofelemer-which-is-Expected-to-Support-Orphan-Drug-Designation-ODD-for-Crofelemer-for-Congenital-Diarrheal-Disorders-CDD
https://www.accesswire.com/622107/Jaguar-Health-Signs-Second-Agreement-for-6-Million-Non-dilutive-Financing-Transaction-Involving-the-Sale-of-Royalty-Rights-Related-to-Future-Mytesi-Crofelemer-and-Lechlemer-Revenue-Stream
https://www.accesswire.com/622107/Jaguar-Health-Signs-Second-Agreement-for-6-Million-Non-dilutive-Financing-Transaction-Involving-the-Sale-of-Royalty-Rights-Related-to-Future-Mytesi-Crofelemer-and-Lechlemer-Revenue-Stream
https://globenewswire.com/news-release/2018/07/25/1541849/0/en/RedHill-Biopharma-Initiates-Co-Promotion-of-HIV-AIDS-Anti-Diarrheal-Drug-Mytesi.html
https://globenewswire.com/news-release/2018/06/28/1531043/0/en/RedHill-Biopharma-Announces-U-S-Co-Promotion-Agreement-with-Napo-Pharmaceuticals-for-HIV-AIDS-Anti-Diarrheal-Drug-Mytesi.html
Market Place
Share 
